CHANGE IN BINDING REACTIVITY OF AN ANTITUMOR MONOCLONAL-ANTIBODY AFTER THE INTRODUCTION OF 2-PYRIDYL DISULFIDE GROUPS

被引:7
作者
ORLANDI, R [1 ]
CANEVARI, S [1 ]
LEONI, F [1 ]
MEZZANZANICA, D [1 ]
RIPAMONTI, M [1 ]
COLNAGHI, MI [1 ]
机构
[1] IST NAZL STUDIO & CURA TUMORI, DIV EXPTL ONCOL E, VIA G VENEZIAN 1, I-20133 MILAN, ITALY
来源
HYBRIDOMA | 1986年 / 5卷 / 01期
关键词
D O I
10.1089/hyb.1986.5.1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1 / 8
页数:8
相关论文
共 28 条
[1]  
BERNHARD MI, 1983, CANCER RES, V43, P4420
[2]  
BJORN MJ, 1985, CANCER RES, V45, P1214
[3]   MONOCLONAL-ANTIBODY AND AN ANTIBODY TOXIN CONJUGATE TO A CELL-SURFACE PROTEOGLYCAN OF MELANOMA-CELLS SUPPRESS INVIVO TUMOR-GROWTH [J].
BUMOL, TF ;
WANG, QC ;
REISFELD, RA ;
KAPLAN, NO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (02) :529-533
[4]  
CANEVARI S, 1983, CANCER RES, V43, P1301
[5]  
CANEVARI S, 1985, J NATL CANCER I
[6]   PROTEIN THIOLATION AND REVERSIBLE PROTEIN-PROTEIN CONJUGATION - N-SUCCINIMIDYL 3-(2-PYRIDYLDITHIO)PROPIONATE, A NEW HETEROBIFUNCTIONAL REAGENT [J].
CARLSSON, J ;
DREVIN, H ;
AXEN, R .
BIOCHEMICAL JOURNAL, 1978, 173 (03) :723-737
[7]   HUMAN-MELANOMA CELLS CAN BE KILLED INVITRO BY AN IMMUNOTOXIN SPECIFIC FOR MELANOMA-ASSOCIATED ANTIGEN-P97 [J].
CASELLAS, P ;
BROWN, JP ;
GROS, O ;
GROS, P ;
HELLSTROM, I ;
JANSEN, FK ;
PONCELET, P ;
RONCUCCI, R ;
VIDAL, H ;
HELLSTROM, KE .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (04) :437-443
[8]   ANTIBODY-DIRECTED CYTO-TOXIC AGENTS - USE OF MONOCLONAL-ANTIBODY TO DIRECT THE ACTION OF TOXIN-A CHAINS TO COLORECTAL-CARCINOMA CELLS [J].
GILLILAND, DG ;
STEPLEWSKI, Z ;
COLLIER, RJ ;
MITCHELL, KF ;
CHANG, TH ;
KOPROWSKI, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (08) :4539-4543
[9]   PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY [J].
GREENWOOD, FC ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1963, 89 (01) :114-&
[10]  
KROLICK KA, 1981, CANCER IMMUNOL IMMUN, V12, P39